News & Insights

News & Insights

< Back to Bio
Jeffrey S. Bucholtz

News 42 results

In the News · Source: Law360

February 11, 2025
Jeffrey Bucholtz and Kellam Conover submit an amicus brief on behalf of the Chamber of the Commerce of the United States in support of Johnson & Johnson before the Delaware Supreme Court in a multibillion-dollar post-acquisition dispute

In the News · Source: Law360

January 21, 2025
Jeffrey Bucholtz, Andrew Michaelson, Christine Carletta, Caroline Freeman and Jared Lax counsel the Federal Reserve Bank of Kansas City in a dispute with a cryptocurrency bank before the U.S. Court of Appeals for the Tenth Circuit

Recognition

June 12, 2024
King & Spalding Earns Top-Tier Rankings in Legal 500 United States 2024 Guide

Recognition

June 6, 2024
King & Spalding Earns 198 Lawyer Rankings, 90 Practice Group Rankings in Chambers USA Guide

In the News · Source: Law360 Real Estate Authority and Law360

May 22, 2024
K&S advises G-Max Management and a group of landlords in a dispute before the U.S. Supreme Court challenging the constitutionality of rent stabilization in the state of New York

In the News · Source: Law360

April 1, 2024
Andrew Michaelson, Angela Tarasi, Christine Carletta, Caroline Freeman, Jared Lax, Jeffrey Bucholtz, Josh Mitchell and Laura Harris counsel the Federal Reserve Bank of Kansas City, which obtained a successful summary judgment

In the News · Source: Law360

March 30, 2024
Jeffrey Bucholtz, Michael Pauze, Matt Noller and Alex Kazam represent William Facteau, former Acclarent Inc. executive, before the U.S. Supreme Court in a case involving off-label marketing

In the News · Source: Law360

December 18, 2023
Jeffrey Bucholtz, Alexander Kazam, Christine Carletta and Gregory Ruehlmann represent Dayton Area Chamber of Commerce in a drug pricing dispute with the HHS

In the News · Source: The Washington Post, Reuters, The Pink Sheet Citeline Regulatory and Bloomberg Law

September 15, 2023
Jeff Bucholtz counsels the U.S. Chamber of Commerce on its challenge over a provision in the Inflation Reduction Act that allows Medicare to negotiate drugs prices

In the News · Source: Bloomberg Law and JD Journal

August 24, 2023
K&S and Jeff Bucholtz are highlighted in profiles examining the major law firms behind seven lawsuits by drugmakers and major trade groups trying to block the Biden administration’s unprecedented drug price negotiation plan from going into effect

In the News · Source: Law360

July 13, 2023
Holmes Hawkins, Russell Blythe, Jeffrey Bucholtz and Joshua Mitchell obtain a favorable dismissal on behalf of BASF in a patent dispute with MacDermid Enthone before the Federal Circuit

In the News · Source: Pink Sheet

June 21, 2023
Jeff Bucholtz comments on the U.S. Supreme Court concluding that the government is not prevented from seeking to dismiss a False Claims Act case if it does not intervene when the case is under seal